Skip to content
Disclosery

EXANE DERIVATIVES: T position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on T, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,440 T shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,440 shares
    Change vs previous 13F -28,332 shares

    0.02% of the 13F portfolio, value $30,176.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 29,772 shares
    Change vs previous 13F -11,595 shares

    0.2% of the 13F portfolio, value $703,459.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 41,367 shares
    Change vs previous 13F +25,602 shares

    0.25% of the 13F portfolio, value $1,017,577.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 15,765 shares
    Change vs previous 13F -9,560 shares

    0.11% of the 13F portfolio, value $425,792.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 25,325 shares
    Change vs previous 13F -67,757 shares

    0.17% of the 13F portfolio, value $715,915.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 93,082 shares
    Change vs previous 13F -16,022 shares

    0.85% of the 13F portfolio, value $2,817,421.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 109,104 shares
    Change vs previous 13F -7,837 shares

    0.95% of the 13F portfolio, value $3,137,634.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 116,941 shares
    Change vs previous 13F not available

    1.09% of the 13F portfolio, value $3,333,849.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).